Table 1.
Subject demographics and characteristics (N = 572)
| %/Mean ± SD/median (25th, 75th percentile) |
Range |
|||
|---|---|---|---|---|
| Initial | Last | Initial | Last | |
| Female sex | 54 | |||
| Nonwhite | 9 | |||
| Age at T1D onset (years) | 7.1 ± 3.4 | 0.2–15.0 | ||
| Age (years) | 11.9 ± 2.9 | 21.7 ± 4.1 | 6.1–17.9 | 10.4–32.1 |
| Diabetes duration | 4.8 ± 3.1 | 14.6 ± 4.8 | 0.5–13.8 | 2.4–27.5 |
| Neither medication/supplement usage | 90 | |||
| Medications usage only | 6 | |||
| Supplements usage only | 2 | |||
| Both medication/supplement usage | 2 | |||
| LDL value (mg/dL)* | 95 ± 29 | 98 ± 35 | 18–247 | 12–255 |
| HDL value (mg/dL) | 55 ± 13 | 60 ± 18 | 22–103 | 9–140 |
| Non-HDL value (mg/dL) | 115 ± 31 | 118 ± 45 | 45–303 | 17–611 |
| Triglycerides (mg/dL) | 89 (60, 133) | 94 (65, 136) | 19–1,331 | 23–1,167 |
| HbA1c (%) | 8.9 ± 1.5 | 8.9 ± 1.7 | 5.5–14.6 | 5.6–16.1 |
| HbA1c (mmol/mol) | 74 ± 16.4 | 74 ± 18.6 | 37–136 | 38–152 |
T1D, type 1 diabetes;
*LDL values were available for only 571 subjects.